In Vitro Models of Bacterial Biofilms: Innovative Tools to Improve Understanding and Treatment of Infections

por Crivello, G., Fracchia, L., Ciardelli, G., Boffito, M., Mattu, C.
Publicado 2023

Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers

por Jackson, AGA, Hill, A, Else, LJ, Back, DJ, Morley, R, Puls, R, Amin, J, Lin, E, Boffito, M
Publicado 2010

Population pharmacokinetic modelling of once-daily ritonavir-boosted darunavir in HIV-infected patients

por Dickinson, L, Jackson, AGA, Garvey, LJ, Watson, V, Khoo, SH, Winston, A, Boffito, M, Davies, GR, Back, DJ
Publicado 2010

Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV‐negative controls

por De Francesco, D, Underwood, J, Bagkeris, E, Boffito, M, Post, FA, Mallon, PWG, Vera, JH, Williams, I, Anderson, J, Johnson, M, Sabin, CA, Winston, A
Publicado 2019

Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study

por Dickinson, L, Amin, J, Else, L, Boffito, M, Egan, D, Owen, A, Khoo, S, Back, D, Orrell, C, Clarke, A, Losso, M, Phanuphak, P, Carey, D, Cooper, DA, Emery, S
Publicado 2015

High‐risk behaviours, and their associations with mental health, adherence to antiretroviral therapy and HIV parameters, in HIV‐positive men who have sex with men

por Pool, ERM, Winston, A, Bagkeris, E, Vera, JH, Mallon, PWG, Sachikonye, M, Post, FA, Pozniak, A, Boffito, M, Anderson, J, Williams, I, Johnson, M, Burgess, L, Sabin, CA
Publicado 2018